Search results
Results from the WOW.Com Content Network
On December 18, 2006, the company's web site stated, "As of November 1, 2006 The See Clearly Method is no longer available for sale." [ 15 ] In response to a 2007 complaint by the California Attorney General's office concerning David Muris' involvement with the See Clearly Method, Muris was placed on probation for five years in 2008 by the ...
See the "Blessing Scam" below. This scam got a new lease on life in the electronic age with the virus hoax. Fake anti-virus software falsely claims that a computer is infected with viruses, and renders the machine inoperable with bogus warnings unless blackmail is paid. In the Datalink Computer Services incident, a mark was fleeced of several ...
Best practices • Don't enable the "use less secure apps" feature. • Don't reply to any SMS request asking for a verification code. • Don't respond to unsolicited emails or requests to send money.
Consumer Reports has been sued several times by companies unhappy with reviews of their products. Consumer Reports has fought these cases vigorously. [ 73 ] [ page needed ] As of October 2000, Consumer Reports had been sued by 13 manufacturers and never lost a case.
The Federal Trade Commission (FTC), along with the New York State Attorney General's office, is angling to give a Wisconsin-based supplement company a legal battle it won't soon forget.Their case ...
Financial scams are among the most common crimes out there. And seniors are taking the brunt of it. The FBI Internet Crime Complaint Center (IC3) received more than 101,000 reports of scams and ...
Receiving a call, email or letter from a company purporting to be a debt collector can spark alarm. Before disclosing any information, look for these eight signs of a fake debt collection scam. 1.
Mayo v. Prometheus, 566 U.S. 66 (2012), was a case decided by the Supreme Court of the United States that unanimously held that claims directed to a method of giving a drug to a patient, measuring metabolites of that drug, and with a known threshold for efficacy in mind, deciding whether to increase or decrease the dosage of the drug, were not patent-eligible subject matter.